Patents Assigned to Oxeia Biopharmaceuticals, Inc.
  • Publication number: 20200261541
    Abstract: The present disclosure provides methods for treating mild brain injury and other neurological disorders in a subject in need thereof, comprising administering to the subject an effective amount of a compound comprising a ghrelin or ghrelin variant.
    Type: Application
    Filed: November 1, 2019
    Publication date: August 20, 2020
    Applicant: Oxeia Biopharmaceuticals, Inc.
    Inventors: Kartik Kiran Shah, Amit Dilip Munshi
  • Publication number: 20180071367
    Abstract: The present disclosure provides methods for treating one or more of cognitive deficits or cognitive impairments associated with or caused by mild brain injuries, chemotherapy treatment, chemotherapy medication, post-chemotherapy cognitive impairment (PCCI), chemo brain, and other disorders arising from cognitive dysfunction in a subject by administering to the subject an effective amount of a composition comprising ghrelin or a ghrelin variant.
    Type: Application
    Filed: March 8, 2016
    Publication date: March 15, 2018
    Applicant: Oxeia Biopharmaceuticals, Inc.
    Inventors: Kartik Kiran SHAH, Amit Dilip MUNSHI, Reema BATRA
  • Publication number: 20170281732
    Abstract: The present disclosure provides methods for treating mild brain injury and other neurological disorders in a subject in need thereof, comprising administering to the subject an effective amount of a compound comprising a ghrelin or ghrelin variant. This invention provides for methods for treating a mild brain injury or concussion in a patient wherein said method comprises administering to the subject in need thereof suffering from said mild brain injury or concussion an effective amount of a ghrelin variant or a composition comprising a ghrelin variant so as to treat said mild brain injury or concussion.
    Type: Application
    Filed: August 18, 2015
    Publication date: October 5, 2017
    Applicant: Oxeia Biopharmaceuticals, Inc.
    Inventors: Kartik Kiran Shah, Amit Dilip Munshi
  • Publication number: 20170266257
    Abstract: The present disclosure provides methods for treating traumatic brain injury and other neurological disorders in a subject in need thereof, comprising administering to the subject an effective amount of a composition comprising ghrelin or a ghrelin variant. This invention provides for methods for treating a severe or moderate traumatic brain injury in a patient wherein said method comprises administering to the subject suffering from said severe or moderate traumatic brain injury a therapeutic effective amount of ghrelin or a ghrelin variant or a composition comprising ghrelin or a ghrelin variant so as to treat said severe or moderate traumatic brain injury.
    Type: Application
    Filed: August 18, 2015
    Publication date: September 21, 2017
    Applicant: Oxeia Biopharmaceuticals, Inc.
    Inventors: Kartik Kiran SHAH, Amit Dilip MUNSHI
  • Publication number: 20170121385
    Abstract: The present disclosure provides methods for treating a neurodegenerative condition or situation in a subject in need thereof, comprising administering to the subject an effective amount of a compound comprising ghrelin or a ghrelin variant.
    Type: Application
    Filed: October 28, 2016
    Publication date: May 4, 2017
    Applicant: Oxeia Biopharmaceuticals, Inc.
    Inventors: Kartik Kiran Shah, Amit Dilip Munshi